Preparation of Magnetic Inks: Adsorption of Macromolecular Dispersion Agents on Magnetic Metallic Iron Pigments and Electrical Charge Formation

The interaction between metallic iron pigments (MPs) and the actual constituents of magnetic ink is examined by first determining the adsorption isotherms and analyzing by FTIR the type of bonding that is established between the constituents and MP. Then, following the approach described in a previous paper using model compounds, the formation of electrical charges on MPs is examined through acoustophorometric (Electrokinetic amplitude or ESA) measurements. It is shown that the variation in ESA is related to charge transfer processes and reflects the MP-constituent interactions. Finally, adsorption competitions are shown and the importance of the method of preparation (order of mixing of the ingredients of the ink) is illustrated. Copyright 1997 Academic Press. Copyright 1997Academic Press

Adsorption of Stearic Acid and Diethylhexyl Phosphate on Magnetic Metallic Iron Pigments: Electrical Surface Charging and Adsorption Competition

The adsorption of stearic acid and bis(2-ethylhexyl) phosphate, from toluene and THF solutions, on magnetic iron pigments (MP) was examined. Adsorption isotherms as well as the concomitant variations of surface electrical (zeta) potential were determined. The formation of electrical surface charges is explained by charge transfer processes between the solvents, the adsorbates, and MP. An adsorption competition is evidenced when contacting MP with the adsorbates using 14C-labeled stearic acid.

Treatment of hydatid disease with high oral doses of mebendazole. Long-term follow-up of plasma mebendazole levels and drug interactions.

Plasma mebendazole levels were analysed retrospectively in patients treated for inoperable infections with Echinococcus multilocularis or granulosus. In 10 patients receiving mebendazole at 4 dose levels there was no relation between dose and plasma concentration. In 17 patients followed on the same dose for more than 18 months, the plasma levels varied with individual coefficients of variation ranging from 27 to 72%. The data reveal the limitations of single measurements of plasma mebendazole and emphasize the need for repeated monitoring. Coadministration of phenytoin and carbamazepine seemed to lower plasma levels, presumably as a result of enzyme induction. It was not possible appreciably to raise the mebendazole concentrations by inhibition of drug metabolizing enzymes with cimetidine.